Achieve life sciences to announce fourth quarter and year-end 2024 financial results and host conference call and webcast on march 11, 2025

Seattle and vancouver, british columbia, march 06, 2025 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its fourth quarter and year-end 2024 financial results and provide an update on the cytisinicline development program on tuesday, march 11, 2025, at 8:30 am edt.
ACHV Ratings Summary
ACHV Quant Ranking